Determination of copy number of c-Myc protein per cell by quantitative Western blotting

被引:43
作者
Rudolph, C
Adam, G
Simm, A
机构
[1] Univ Konstanz, Fak Biol, Arbeitsgrp Zellbiol Tumorbiol, D-78457 Constance, Germany
[2] Biozentrum, D-97074 Wurzburg, Germany
关键词
D O I
10.1006/abio.1999.3095
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The protooncogene c-Myc plays a key role in growth control, differentiation, and apoptosis. An abnormally high expression of c-myc has been found to be associated with many neoplasms. c-Myc gene expression is usually measured at the mRNA level Few studies have been published on quantitative Myc protein determination. A major drawback of ELISA (enzyme-linked immunosorbent assay) methods is the uncertainty of the specificity of the antibody reaction. In contrast, antibody specificity can be easily controlled by Western/immunoblotting. Here we describe a method to quantify c-Myc protein in primary human IMR90 lung fibroblasts based on Western blotting Using a high-resolution polyacrylamide gel, we were able to differentiate the cellular c-Myc protein (64 kDa) from a c-Myc internal standard (65 kDa). We determined both the total c-Myc protein content per cell and its distribution in the cytoplasmic and nuclear fractions. About 4000 c-Myc protein molecules were detected in the cytoplasmic fraction and 29,000 copies in the nuclear fraction for proliferating human limp fibroblasts IMR90. The ratio of nuclear (active) to cytoplasmic (inactive) c-Myc protein changed from 17:1 for proliferating cells to 2.5:1 for confluent cells. (C) 1999 Academic Press.
引用
收藏
页码:66 / 71
页数:6
相关论文
共 48 条
[1]   LEVEL OF RIBOSOMAL-RNA REQUIRED FOR STIMULATION FROM QUIESCENCE INCREASES DURING CELLULAR AGING INVITRO OF MAMMALIAN FIBROBLASTS [J].
ADAM, G ;
SIMM, A ;
BRAUN, F .
EXPERIMENTAL CELL RESEARCH, 1987, 169 (02) :345-356
[2]   MYC-MAX-MAD - A TRANSCRIPTION FACTOR NETWORK CONTROLLING CELL-CYCLE PROGRESSION, DIFFERENTIATION AND DEATH [J].
AMATI, B ;
LAND, H .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1994, 4 (01) :102-108
[3]   TRANSCRIPTIONAL ACTIVATION BY THE HUMAN C-MYC ONCOPROTEIN IN YEAST REQUIRES INTERACTION WITH MAX [J].
AMATI, B ;
DALTON, S ;
BROOKS, MW ;
LITTLEWOOD, TD ;
EVAN, GI ;
LAND, H .
NATURE, 1992, 359 (6394) :423-426
[4]   A RAPID MICROPREPARATION TECHNIQUE FOR EXTRACTION OF DNA-BINDING PROTEINS FROM LIMITING NUMBERS OF MAMMALIAN-CELLS [J].
ANDREWS, NC ;
FALLER, DV .
NUCLEIC ACIDS RESEARCH, 1991, 19 (09) :2499-2499
[5]  
Bao JX, 1996, ONCOGENE, V12, P2171
[6]   INTERACTION OF C-MYC WITH THE PRB-RELATED PROTEIN P107 RESULTS IN INHIBITION OF C-MYC-MEDIATED TRANSACTIVATION [J].
BEIJERSBERGEN, RL ;
HIJMANS, EM ;
ZHU, L ;
BERNARDS, R .
EMBO JOURNAL, 1994, 13 (17) :4080-4086
[7]   THE ORNITHINE DECARBOXYLASE GENE IS A TRANSCRIPTIONAL TARGET OF C-MYC [J].
BELLOFERNANDEZ, C ;
PACKHAM, G ;
CLEVELAND, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (16) :7804-7808
[8]   SEQUENCE-SPECIFIC DNA-BINDING BY THE C-MYC PROTEIN [J].
BLACKWELL, TK ;
KRETZNER, L ;
BLACKWOOD, EM ;
EISENMAN, RN ;
WEINTRAUB, H .
SCIENCE, 1990, 250 (4984) :1149-1151
[9]   Myc versus USF: Discrimination at the cad gene is determined by core promoter elements [J].
Boyd, KE ;
Farnham, PJ .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (05) :2529-2537
[10]   CELL-CYCLE CONTROL OF C-MYC BUT NOT C-RAS EXPRESSION IS LOST FOLLOWING CHEMICAL TRANSFORMATION [J].
CAMPISI, J ;
GRAY, HE ;
PARDEE, AB ;
DEAN, M ;
SONENSHEIN, GE .
CELL, 1984, 36 (02) :241-247